Archives
-
From SHP2 Mutations to Stable Plant Proteomes
2026-09-09
Mechanistic studies of SHP2 show how subtle conformational changes can reshape signaling and disease interpretation. This thought-leadership article connects that lesson to plant cell protein stability, explaining why broad-spectrum protein degradation inhibition and disciplined extract handling are strategic requirements for translational research.
-
Calpain Inhibitor I, ALLN: Practical Lab Guide
2026-09-09
Calpain Inhibitor I, ALLN (SKU A2602) is a DMSO-soluble cysteine-protease inhibitor for experiments examining calpain and cathepsin involvement in apoptosis, inflammation, and ischemia-reperfusion injury. Use it with vehicle controls and orthogonal readouts; it is not intended for diagnostic, therapeutic, or medical applications, and its multi-protease profile limits single-target interpretation.
-
HDAC Inhibitors Repress NUT Carcinoma Function
2026-09-08
Shiota et al. developed a dCAS9-based chemical screen that identified structurally diverse HDAC inhibitors as suppressors of NUT-dependent transcription in NUT carcinoma. The study connects HDAC inhibition with BRD4-NUT megadomain disruption, tumor-cell differentiation, and improved xenograft control when combined with bromodomain inhibition.
-
AEBSF.HCl in Protease and Necroptosis Workflows
2026-09-08
AEBSF.HCl provides irreversible, broad-spectrum serine protease control for cell lysates, APP-processing experiments, and leukemic cell-lysis models. Its strongest value is as a practical perturbation and sample-protection reagent, provided researchers distinguish serine-protease effects from the cathepsin-centered mechanism of necroptosis.
-
Z-VDVAD-FMK in Apoptosis Pathway Research
2026-09-07
Z-VDVAD-FMK helps researchers separate caspase-2-associated mitochondrial apoptosis from caspase-independent and pyroptotic death. This practical guide connects inhibitor handling, assay design, pathway-specific readouts, and troubleshooting for cancer research and mechanistic cell-death studies.
-
CPI-613: A Metabolism-to-Immunity Research Framework
2026-09-07
CPI-613, also known as 6,8-bis(benzylsulfanyl)octanoic acid, links mitochondrial bioenergetics to tumor–immune communication. This article translates recent PDHA1 succinylation findings into practical decisions for apoptosis assays, tumor cell metabolism studies, and combination-treatment experiments.
-
Tofacitinib citrate: Reliable Cell Assays
2026-09-05
This scenario-based guide explains how Tofacitinib citrate (CP-690550 citrate), SKU A4135, can support interpretable viability, proliferation, and inflammatory-cell assays. It combines formulation guidance, concentration selection, controls, and literature-based cautions for JAK-STAT and endothelial research.
-
Proteinase K for DNA and EV Workflows
2026-09-04
Proteinase K combines broad protein digestion with compatibility across common molecular-biology buffers, making it useful for genomic DNA isolation and controlled extracellular-vesicle surface assays. This guide translates its practical strengths into executable workflows while showing how the Candida albicans EV study can inform assay controls without overstating what the paper tested.
-
Z-VAD-FMK in Cell-Death Mechanism Studies
2026-09-04
Z-VAD-FMK helps researchers distinguish caspase-dependent apoptosis from alternative forms of regulated cell death in immune, epithelial, and cancer models. Its greatest value emerges when pharmacological inhibition is paired with time-resolved viability, caspase activity measurement, and orthogonal pathway readouts.
-
Solanesol B8776: Practical Workflow Guide
2026-09-03
Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical, membrane-related, and cell-based workflow development. This guide explains DMSO preparation, storage, controls, and troubleshooting while defining why the material should not be used directly in water- or ethanol-based systems or for diagnostic and medical applications.
-
Urolithin A: Mitochondrial Quality Control Guide
2026-09-03
Urolithin A is a gut microbiota-derived metabolite studied as a mitophagy activator for mitochondrial quality control. Preclinical and clinical evidence supports mitochondrial and skeletal-muscle research applications, while fibrosis and immune findings remain model-specific.
-
Talabostat mesylate in T-Cell Pyroptosis Assays
2026-09-02
Talabostat mesylate, also called PT-100 or Val-boroPro, is a practical probe for connecting dipeptidyl peptidase biology with CARD8-dependent pyroptosis, immune-cell state, and tumor-associated protease activity. This workflow-focused guide covers assay setup, concentration planning, orthogonal readouts, FAP/DPP4 applications, and troubleshooting without treating exploratory findings as therapeutic proof.
-
Leupeptin: Reliable Assay Protease Control
2026-09-02
Learn how Leupeptin, Microbial (Leupeptin hemisulfate), SKU A2570, can improve mechanistic interpretation in cell viability, proliferation, cytotoxicity, autophagy, and protease workflows. This scenario-based guide covers formulation, fresh-solution handling, assay compatibility, data interpretation, and practical supplier selection.
-
CRTC–CREB Sensing of Proteotoxic Stress in Drosophila
2026-09-01
The reference study identifies CRTC–CREB as a stress-responsive transcriptional sensor that links proteasome inhibition to ROS–JNK signaling and enhanced proteostasis. Using compound screening, transcriptomics, genetic manipulation, and Huntington’s disease models, the authors show that activating this axis can reduce protein aggregation and improve functional outcomes in Drosophila.
-
Phosphorylation Controls BMAL1 Condensates
2026-09-01
BMAL1 phase separation introduces a spatial dimension to circadian phosphorylation biology. This thought-leadership guide shows how Lambda Protein Phosphatase (RNase-free) and λ-PPase controls can help translational researchers distinguish phosphorylation-dependent condensate behavior from changes in protein abundance, antibody performance, or sample quality.